163 related articles for article (PubMed ID: 1339180)
1. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
[TBL] [Abstract][Full Text] [Related]
2. Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry.
Gan FY; Gesell MS; Alousi M; Luk GD
J Histochem Cytochem; 1993 Aug; 41(8):1185-96. PubMed ID: 7687263
[TBL] [Abstract][Full Text] [Related]
3. Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma.
Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Kinoshita H; Otani S
Hepatology; 1994 Nov; 20(5):1179-86. PubMed ID: 7927250
[TBL] [Abstract][Full Text] [Related]
4. Point mutation of ornithine decarboxylase gene in human hepatocellular carcinoma.
Tamori A; Nishiguchi S; Kuroki T; Koh N; Kobayashi K; Yano Y; Otani S
Cancer Res; 1995 Aug; 55(16):3500-3. PubMed ID: 7627954
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
Mafune K; Tanaka Y; Mimori K; Mori M; Takubo K; Makuuchi M
Clin Cancer Res; 1999 Dec; 5(12):4073-8. PubMed ID: 10632342
[TBL] [Abstract][Full Text] [Related]
6. Relationship between ornithine decarboxylase gene abnormalities and human hepatocarcinogenesis.
Koh N; Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Tanaka T; Kinoshita H; Yano Y; Otani S
Hepatogastroenterology; 1999; 46(26):1100-5. PubMed ID: 10370674
[TBL] [Abstract][Full Text] [Related]
7. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
8. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
[TBL] [Abstract][Full Text] [Related]
9. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis].
Fu XM; Yang QX; Shao CK; Feng ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):821-3. PubMed ID: 16793609
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
13. Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
Nagao T; Ishida Y; Kondo Y
Mod Pathol; 1996 Feb; 9(2):99-104. PubMed ID: 8657727
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of endothelin-1/big endothelin-1 in normal liver, liver cirrhosis and hepatocellular carcinoma.
Suzuki T; Hoshi N; Watanabe K; Kasukawa R; Suzuki T
Fukushima J Med Sci; 1998 Dec; 44(2):93-105. PubMed ID: 10091381
[TBL] [Abstract][Full Text] [Related]
15. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
Chen L; Shen AG; Wang GL; Lu P; Li XY
Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
[TBL] [Abstract][Full Text] [Related]
17. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of the ornithine decarboxylase gene in human esophageal cancer.
Yoshida M; Hayashi H; Taira M; Isono K
Cancer Res; 1992 Dec; 52(23):6671-5. PubMed ID: 1423312
[TBL] [Abstract][Full Text] [Related]
19. In situ RT-PCR allows the detection of ornithine decarboxylase mRNA in paraffin embedded archival human hyperplastic breast tissues.
Clerico L; Mancuso T; Da Prato L; Marziliano N; Garagna S; Pecile V; Demori E; Morgutti M; Città A; Parodi S; Amoroso A; Crovella S
Eur J Histochem; 1999; 43(3):179-83. PubMed ID: 10563250
[TBL] [Abstract][Full Text] [Related]
20. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]